JUBLINGREA - IntraDay Trade Analysis with Live Signals
← Back to ListKey Parameters
⭐ IntraDay Trade Rating: 3.8
✅ Positive
The stock is showing strong momentum indicated by the rising price and increasing volume, alongside a significant quarter-over-quarter profit growth of 114%. Furthermore, the relatively low debt-to-equity ratio suggests financial stability.
⚠️ Limitation
The high P/E ratio of 34.8 indicates that the stock may be overvalued compared to its earnings, which could limit upside potential. Volume is above average but still significantly lower than the weekly average, potentially signaling waning momentum.
📉 Company Negative News
Recent news highlights Jubilant Ingrevia's announcements regarding the Annual General Meeting and final dividend, without detailing any significant negative factors or concerns. Additionally, filings with SEBI indicate ongoing compliance efforts related to BRSR disclosures, which is a standard process rather than concerning news.
📈 Company Positive News
The company announced its 7th Annual General Meeting and finalized the final dividend payment for FY 2025-26, suggesting continued profitability and shareholder returns.
🏭 Industry
Jubilant Ingrevia operates within the specialty chemicals sector, which is currently experiencing moderate growth driven by increasing demand from various industries like pharmaceuticals, agrochemicals, and paints & coatings. The industry's outlook remains relatively positive but sensitive to global economic conditions and regulatory changes.
🧾 Conclusion
A buy price of 745 ₹ would be suitable, targeting an initial profit-taking level at 760 ₹, representing a 1.8% gain. Alternatively, set a stop-loss order at 735 ₹ to protect against potential downside if the momentum stalls. Overall, the stock presents a moderate trading opportunity due to recent growth and volume, but careful monitoring of price action is advised.